Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Innovative Medicines Canada
Business AssociationsCanada
Last verified 3 months agoinnovativemedicines.ca
Innovative Medicines Canada (IMC), headquartered in Ottawa, Ontario, is a leading business association representing the innovative pharmaceutical industry in Canada. Founded in 2014, IMC advocates for policies that foster innovation and improve patient access to life-saving medicines. The organisation plays a crucial role in shaping the regulatory landscape and promoting the value of innovative therapies across the country.
With a focus on research, development, and market access, IMC supports its members in navigating the complexities of the healthcare system. Its unique position as a voice for the industry enables it to influence key stakeholders and drive meaningful change. Notable achievements include successful collaborations with government bodies and contributions to national health strategies, solidifying IMC's reputation as a pivotal player in the Canadian healthcare ecosystem.
21
DitchCarbon score
+1 vs industry average
Innovative Medicines Canada’s score of 21 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Innovative Medicines Canada?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Business Associations has below-average carbon intensity
Industry performance
0.199
20182025
The Business Associations industry has reduced its overall emissions by 37% since 2018
Reported emissions
No reported emissions data is available for Innovative Medicines Canada yet.
Innovative Medicines Canada's reported carbon emissions
Innovative Medicines Canada, a Canadian-headquartered business association, has not publicly reported its carbon emissions data. The organisation has not disclosed any specific climate commitments or reduction targets.
Assessing Innovative Medicines Canada as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Innovative Medicines Canada and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Innovative Medicines Canada’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Innovative Medicines Canada yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Innovative Medicines Canada3 months ago
21
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more